ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0964

Is Meniscal Status in the Anterior Cruciate Ligament Injured Knee Associated with Change in Bone Surface Area? An Exploratory Analysis of Data from the KANON Trial

Barbara Snoeker1, Aleksandra Turkiewicz1, Mike Bowes2, Frank Roemer3, Stefan Lohmander1, Richard Frobell1 and Martin Englund1, 1Lund University, Lund, Sweden, 2Imorphics Ltd, Manchester, United Kingdom, 3Boston University School of Medicine, Boston, MA, and Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany, Erlangen, Germany

Meeting: ACR Convergence 2020

Keywords: bone biology, Magnetic resonance imaging (MRI), Orthopedics, Osteoarthritis, Trauma

  • Tweet
  • Email
  • Print
Session Information

Date: Saturday, November 7, 2020

Title: Orthopedics, Low Back Pain, & Rehabilitation (0960–0964)

Session Type: Abstract Session

Session Time: 10:00AM-10:50AM

Background/Purpose: Bone shape changes, which may be an important feature of osteoarthritis (OA) development, have been observed to occur early in the knee after anterior cruciate ligament (ACL) injury. The association between co-existing meniscal damage and bone shape changes is unclear. To gain new knowledge of early joint changes post-trauma, we studied the association between meniscal status in the ACL-injured knee and differences in bone surface area.

Methods: We used data from the KANON trial including 121 young ACL-injured adults. We obtained baseline and 2-year follow up knee MRIs read by one musculoskeletal radiologist. Our outcome was bone surface area at 2 years (mean mm2, log-transformed) in 4 regions (femur, tibia, patella, and trochlea femur) in the medial and lateral compartment. We used data as reported by Bowes et al, who determined bone surfaces of the different areas and their limits with the use of active appearance models, a form of statistical shape model.1 We defined meniscal damage based on Anterior Cruciate Ligament Osteoarthritis Score  (ACLOAS).(Table 1) Meniscal damage was defined as both present at baseline and newly developed. Newly developed meniscal damage includes incident or worsening, i.e. pre-existing tears that expanded to another segment, or to extrusion or incident loss of meniscus substance.(Table 1) We used multilevel linear regression adjusted for baseline bone area, age, sex, body mass index, treatment arm (i.e. early and optional delayed ACL reconstruction), and location. We compared bone area changes in subjects with meniscal damage at baseline or newly developed to those without meniscal damage. We present results as percentage (%) difference in bone area between the groups with 95% confidence intervals (CI).

Results: We included 121 subjects (median age 25 (18-36) years, 81% men). Due to missing MRI information, 109 subjects were analyzed. Baseline bone area in mean mm2 were similar in those with and without meniscal damage for all four regions (Table 2). In the whole cohort, the bone surface area increased on average by ~2% over 2 years, with ~1% higher increase for both subjects with ipsicompartmental meniscal damage at baseline and with newly developed meniscal damage compared to those without meniscal damage during the 2-year follow-up (Figure 1).

Conclusion: In the ACL-injured knee, persons with baseline or newly developed meniscal damage had ~1% increased bone area in the affected compartment compared to persons without such meniscal damage. The clinical relevance of early bone shape changes for future structural and clinical outcomes needs further exploration.


Disclosure: B. Snoeker, None; A. Turkiewicz, None; M. Bowes, Imorphics Ltd, 4; F. Roemer, Boston Imaging Core Lab (BICL), LLC, 1, Calibr - California Institute for Biomedical Research, 1; S. Lohmander, None; R. Frobell, None; M. Englund, Pfizer, 5.

To cite this abstract in AMA style:

Snoeker B, Turkiewicz A, Bowes M, Roemer F, Lohmander S, Frobell R, Englund M. Is Meniscal Status in the Anterior Cruciate Ligament Injured Knee Associated with Change in Bone Surface Area? An Exploratory Analysis of Data from the KANON Trial [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/is-meniscal-status-in-the-anterior-cruciate-ligament-injured-knee-associated-with-change-in-bone-surface-area-an-exploratory-analysis-of-data-from-the-kanon-trial/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-meniscal-status-in-the-anterior-cruciate-ligament-injured-knee-associated-with-change-in-bone-surface-area-an-exploratory-analysis-of-data-from-the-kanon-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology